Page last updated: 2024-09-03

l 158809 and Diabetic Neuropathies

l 158809 has been researched along with Diabetic Neuropathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Coppey, LJ; Davidson, EP; Gellett, JS; Lund, DD; Oltman, CL; Rinehart, TW; Yorek, MA	1

Other Studies

1 other study(ies) available for l 158809 and Diabetic Neuropathies

Article	Year
ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats. Diabetes, 2006, Volume: 55, Issue:2 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Therapy, Combination; Enalapril; Imidazoles; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Oxidative Stress; Rats; Rats, Sprague-Dawley; Tetrazoles	2006

Article

Year

ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats.

Diabetes, 2006, Volume: 55, Issue:2

Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Therapy, Combination; Enalapril; Imidazoles; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Oxidative Stress; Rats; Rats, Sprague-Dawley; Tetrazoles

2006